台股 » 個股 » 醣聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

醣聯

(4168)
可現股當沖
  • 股價
    23.80
  • 漲跌
    ▼0.05
  • 漲幅
    -0.21%
  • 成交量
    109
  • 產業
    上櫃 生技醫療類股▲0.61%
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
醣聯 (4168)籌碼相關-富邦-頭份 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-頭份 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/0700.00324.6524.75-3161-1.85%
2024/11/2100.00124.8024.90-1169-0.59%
2024/10/1800.000.225.6525.70-0.2283-0.07%
2024/10/0900.00225.7025.65-2362-0.55%
2024/10/080.226.3500.0026.150.23660.05%
2024/09/2500.00125.5025.45-1486-0.21%
2024/09/0500.00125.7525.90-1743-0.13%
2024/08/3000.00127.3027.10-1768-0.13%
2024/08/26127.7500.0027.4018980.11%
2024/08/2200.00227.8027.55-2900-0.22%
2024/08/2100.00127.5027.30-1901-0.11%
2024/08/20127.6000.0027.3519000.11%
2024/08/19027.1800.0027.1008950.00%
2024/08/1200.00125.6525.60-1880-0.11%
2024/08/0800.00225.6525.50-2877-0.23%
2024/08/0700.00625.7325.70-6875-0.68%
2024/08/06124.6000.0024.8018710.11%
2024/08/0100.00127.7527.70-1846-0.12%
2024/07/2300.00129.5029.60-1817-0.12%
2024/07/17530.9500.0030.9057590.66%
2024/07/15131.0000.0030.5017440.13%
2024/07/1200.00529.8229.50-5723-0.69%
2024/07/11529.7000.0029.5057190.69%
2024/07/09331.05130.1030.3527130.28%
2024/07/08231.0500.0031.0527080.28%
2024/07/05230.751029.9331.00-8692-1.16%
2024/07/04129.4500.0029.2517050.14%
2024/07/03229.4000.0029.6527200.28%
2024/07/02829.6600.0029.4587141.12%
2024/07/01530.32130.5030.4046960.57%
2024/06/28830.38130.3530.1076791.03%
2024/06/27931.04231.0530.0076561.07%
2024/06/2600.00330.7530.65-3600-0.50%
2024/06/2400.00428.9428.75-4496-0.81%
2024/06/2100.00427.2826.95-4459-0.87%
2024/06/17227.00127.1026.8014460.22%
2024/06/04327.5000.0027.5034300.70%
2024/06/03128.70128.3027.7504430.00%
2024/05/2300.00125.1025.00-1321-0.31%
2024/05/2100.00125.3025.45-1325-0.31%
2024/04/11227.00127.0527.4013060.33%
2024/04/1000.00128.6028.05-1293-0.34%
2024/04/09125.15227.0027.25-1251-0.40%
2024/04/03124.8500.0025.0012420.41%
2024/04/01125.00224.9025.10-1244-0.41%
2024/03/28025.1700.0024.6502470.00%
2024/03/1400.00125.7025.35-1261-0.38%
2024/02/15227.1000.0027.1522280.87%
醣聯生物相似藥正式進入臨床三期 2026年Q2解盲Anue鉅亨-2024/12/17
醣聯完成生物相似藥一期試驗 Q4啟動三期臨床Anue鉅亨-2024/08/19
醣聯 相關文章
醣聯 相關影音